Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrrolotriazine kinase inhibitors

Pyrrolotriazine kinase inhibitors

US Patent 8212031 · Granted Jul 3, 2012

Estimated economic value: $122,598,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted quinazolinyl compounds useful as T cell activators2025
Substituted piperazine derivatives useful as T cell activators2025
Substituted bicyclic compounds useful as T cell activators2024
Naphthyridinone compounds useful as T cell activators2024
Substituted naphthyridinone compounds useful as T cell activators2023
Substituted pyridopyrimidinonyl compounds useful as T cell activators2023
TGF-beta inhibitors2022
TGF beta receptor antagonists2021
Substituted naphthyridinone compounds useful as T cell activators2021
Substituted naphthyridinone compounds useful as T cell activators2020
TGF-β inhibitors2019
GDF-8 inhibitors2018